Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-10-04 5:14 pm Unchanged | 2022-09-29 | 13D | Solid Biosciences Inc. SLDB | RA CAPITAL MANAGEMENT L.P. | 829,858 11.010% | 0 (Unchanged) | Filing History |
| 2022-10-03 4:30 pm Purchase | 2022-09-21 | 13G | Alpine Immune Sciences, Inc. ALPN | RA CAPITAL MANAGEMENT L.P. | 4,356,632 9.910% | 4,356,632 (New Position) | Filing History |
| 2022-09-27 10:40 am Purchase | 2022-09-15 | 13G | Magenta Therapeutics, Inc. MGTA | RA CAPITAL MANAGEMENT L.P. | 3,588,081 6.090% | 3,588,081 (New Position) | Filing History |
| 2022-09-26 5:29 pm Sale | 2022-09-26 | 13D | POINT Biopharma Global Inc. PNT | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -9,003,018 (Position Closed) | Filing History |
| 2022-09-26 4:37 pm Purchase | 2022-09-15 | 13G | Cogent Biosciences, Inc. COGT | RA CAPITAL MANAGEMENT L.P. | 3,588,081 6.090% | 3,588,081 (New Position) | Filing History |
| 2022-09-26 4:29 pm Purchase | 2022-09-15 | 13G | Third Harmonic Bio, Inc. THRD | RA CAPITAL MANAGEMENT L.P. | 3,475,687 8.620% | 3,475,687 (New Position) | Filing History |
| 2022-09-16 4:29 pm Unchanged | 2022-09-14 | 13D | POINT Biopharma Global Inc. PNT | RA CAPITAL MANAGEMENT L.P. | 9,003,018 8.650% | 0 (Unchanged) | Filing History |
| 2022-09-06 4:50 pm Purchase | 2022-09-02 | 13D | Solid Biosciences Inc. SLDB | RA CAPITAL MANAGEMENT L.P. | 829,858 11.010% | 5,333 (+0.65%) | Filing History |
| 2022-09-06 4:30 pm Purchase | 2022-08-24 | 13G | Cogent Biosciences, Inc. COGT | RA CAPITAL MANAGEMENT L.P. | 3,612,207 5.490% | 3,612,207 (New Position) | Filing History |
| 2022-09-02 4:30 pm Purchase | 2022-08-31 | 13D | Forma Therapeutics Holdings, Inc. FMTX | RA CAPITAL MANAGEMENT L.P. | 9,040,309 18.880% | 11,125 (+0.12%) | Filing History |
| 2022-08-29 5:01 pm Purchase | 2022-08-25 | 13D | POINT Biopharma Global Inc. PNT | RA CAPITAL MANAGEMENT L.P. | 9,003,018 9.900% | 147,000 (+1.66%) | Filing History |
| 2022-08-26 4:38 pm Purchase | 2022-08-16 | 13G | Fulcrum Therapeutics, Inc. FULC | RA CAPITAL MANAGEMENT L.P. | 7,000,000 13.450% | 7,000,000 (New Position) | Filing History |
| 2022-08-15 5:19 pm Sale | 2022-08-15 | 13G | scPharmaceuticals Inc. SCPH | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -2,691,770 (Position Closed) | Filing History |
| 2022-08-15 5:15 pm Sale | 2022-08-15 | 13G | MacroGenics, Inc. MGNX | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -6,103,594 (Position Closed) | Filing History |
| 2022-08-15 5:12 pm Sale | 2022-08-15 | 13G | KalVista Pharmaceuticals, Inc. KALV | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -1,930,322 (Position Closed) | Filing History |
| 2022-08-15 5:10 pm Sale | 2022-08-15 | 13G | TScan Therapeutics, Inc. TCRX | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -1,255,317 (Position Closed) | Filing History |
| 2022-08-15 5:06 pm Sale | 2022-08-15 | 13G | CYTEIR THERAPEUTICS INC CYTT | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -3,350,506 (Position Closed) | Filing History |
| 2022-08-15 5:04 pm Sale | 2022-08-15 | 13G | Akouos, Inc. AKUS | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -2,281,249 (Position Closed) | Filing History |
| 2022-08-15 4:59 pm Sale | 2022-08-15 | 13G | Edgewise Therapeutics, Inc. EWTX | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -2,613,623 (Position Closed) | Filing History |
| 2022-08-12 4:32 pm Purchase | 2009-02-28 | 13D | 89bio, Inc. ETNB | RA CAPITAL MANAGEMENT L.P. | 4,304,447 14.570% | 12,566 (+0.29%) | Filing History |